| Term 
 | Definition 
 
        | treats acute gout and prevents gouty arthritis depolymerizes microtubules preventing PMNs from phagocytosing crystals
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX inhibitor treats acute gout
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Competitive inhibitor of XO metabolized to a suicide inhibitor of XO
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct inhibitor of oxidized and reduced XO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | uricosuric agent that inhibits the transport of organic anions across the brush border of the kidney |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ureate oxidase analog converts ureate to allantoin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct vasodilator stimulates cGMP cascade to relax vessels
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Verapimil/diltiazem (Angina properties) |  | Definition 
 
        | ↓ HR, myocardial contractility which decreases O2 demand by the heart |  | 
        |  | 
        
        | Term 
 
        | nifedipine/felodipine (Angina properties) |  | Definition 
 
        | vasodilators that decrease afterload and therefore decrease O2 demand |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ↓ HR therefore ↓ afterload and ↓ O2 demand |  | 
        |  | 
        
        | Term 
 
        | Effect of combining β blockers with Nitrates |  | Definition 
 
        | decreased LV EDP and dilates coronary arteries |  | 
        |  | 
        
        | Term 
 
        | Effect of combining β blockers with CCBs |  | Definition 
 
        | prevent coronary vasospasms and decrease TPR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increases glucose oxidation and efficiency of O2 utilization in the heart |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class IA antiarrhythmic Na+ channel blocker, that slows conduction at lower HR
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class IB antiarrhythmic slows conduction at fast rates
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class IC antiarrhythmic pronounced slowing of conduction
 |  | 
        |  | 
        
        | Term 
 
        | Propranolol, metoprolol, timolol, acebutolol (antiarrhythmic properties) |  | Definition 
 
        | Class II antiarrhythmic decreases automaticity related to catecholamines
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class III antiarrhythmic K+ channel blocker that prolongs phase 3 repolarization
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class III antiarrhythmic K+ channel blocker that prolongs phase 3 repolarization
 |  | 
        |  | 
        
        | Term 
 
        | Verapamil/diltiazem (antiarrhythmic properties) |  | Definition 
 
        | Class IV antiarrhythmic decreases SA node automaticity and AVN conduction
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Increased vagal nerve activity to heart leading to decreased SA node automaticity and AV conduction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | terminates PSVT by blocking AVN. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class IA antiarrhythmic [T] > 1 s
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class IA antiarrhythmic [T] > 1 s
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class IB antiarrhythmic [T] < 10 s
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class IC antiarrhythmic [T] > 10 s
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class III antiarrhythmic K+ channel blocker that prolongs phase 3 repolarization
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class III antiarrhythmic K+ channel blocker that prolongs phase 3 repolarization
 |  | 
        |  |